Genmab — Juni 2015
-
København, Danmark, 2. juni 2015 — Genmab A/S (OMX: GEN) offentliggjorde i dag, at selskabets CEO, Jan van de Winkel, ph.d., vil give en præsentation om Genmab ved den 36. årlige Goldman Sachs Global Healthcare konference i Rancho Palos Verdes, Californien den 9. juni 2015 kl. 16.00 lokal tid /den 10. juni 2015 kl. 1.00 dansk tid
-
Fedt.
-
Ved vi, at det er Torben? Abstract #LBA8512 View Abstract
11:21 AM - 11:33 AM
Phase II study of daratumumab (DARA) monotherapy in patients with ≥ 3 lines of prior therapy or double refractory multiple myeloma (MM): 54767414MMY2002 (Sirius). Sagar Lonial, MD Disclosure
Winship Cancer Institute, Emory University School of Medicine -
Jeg tror ikke det er plesner der har noget med det forsøg at gøre? mener kun han har stået for de 2 forsøg der er lavet i genmab regi og ikke dem J&J har igangsat
-
Herudover har Plesner hvis HTF forsøget
-
Rigshospitalet ?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind